US6140316A
|
|
Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions
|
WO9803207A1
|
|
Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety
|
CN1225098A
|
|
19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
|
WO9727887A1
|
|
Device and method for delivery of matter to the vomeronasal organ
|
US6057439A
|
|
Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
|
US5922699A
|
|
19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
|
US5883087A
|
|
Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
|
US6066627A
|
|
Steroids as neurochemical initiators of change in human blood levels of LH
|
PL319601A1
|
|
Hypothalamus action stimulating novel estrenes
|
US5994333A
|
|
Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
|
US5925774A
|
|
Estrenes for inducing hypothalamic effects
|
US5633392A
|
|
Estrenes for inducing hypothalamic effects
|
US5969168A
|
|
Androstanes for inducing hypothalamic effects
|
US5563131A
|
|
Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
|
US5783571A
|
|
Method of altering hypothalamic function by nasal administration of estrene steroids
|
NZ257218A
|
|
Androstane steroid-containing medicament for nasal administration
|
NZ330376A
|
|
Androstane steroid ligands as neurochemical initiators of change in human hypothalamic and autonomic function
|
TW289730B
|
|
Pharmaceutical composition for alleviating the symptoms of psychoses, depression or anxiety comprising androstene steroids
|
US5303703A
|
|
Combined neuroepithelial sample delivery electrode device and methods of using same
|